ONCOCYTIC VARIANT OF THYROID
UP State Journal of Otorhinolaryngology and Head and Neck Surgery · 30.06.2026 · 52
DOI: 10.36611/upjohns/volume14/issue1/10 ↗Kurz gefasst
Fachartikel in der Zeitschrift UP State Journal of Otorhinolaryngology and Head and Neck Surgery, online erschienen am 30.06.2026. Verfasst von Deepa Lakshmi Tanthry. Die Arbeit nennt 4 Literaturangaben.
Abstract (Originalsprache)
Hürthle cell carcinoma (HCC) is a rare subtype of thyroid cancer, accounting for approximately 3–4% of all thyroid malignancies. It is considered more aggressive than other oncocytic thyroid neoplasms. Due to its rarity, its biological behavior and pathological features remain incompletely understood. HCC predominantly affects women and is most commonly diagnosed in individuals in their fifth and sixth decades of life.
Methods
This study reviews the clinical, cytological, and pathological characteristics of HCC, with emphasis on diagnostic challenges, imaging findings, surgical management, and cellular morphology. Data were synthesized from existing literature and cytological observations, including ultrasonographic and histopathological features.
Results
Preoperative diagnosis of HCC is challenging. Indicators of malignancy include male sex, older age, tumor size greater than 4 cm, solid nodules with irregular margins, and psammoma calcifications on ultrasonography. Surgical management varies: thyroid lobectomy is adequate for small, unifocal, intrathyroidal tumors or cases with clinically evident cervical lymph-node metastasis, whereas tumors larger than 4 cm require total thyroidectomy. The benefit of radioactive iodine therapy remains controversial. Cytologically, Hürthle cells are large with abundant eosinophilic, granular cytoplasm due to mitochondrial accumulation, and possess large hyperchromatic nuclei with prominent nucleoli. Distinguishing true Hürthle cells from oncocytic metaplasia is difficult; ultrastructural examination shows that true Hürthle cells have densely packed mitochondria and loss of cell polarity, unlike metaplastic cells.
Discussion
HCC presents significant diagnostic and therapeutic challenges due to overlapping features with benign oncocytic lesions and lack of definitive biomarkers. Accurate differentiation between neoplastic and metaplastic oncocytic cells relies on ultrastructural characteristics rather than immunohistochemical quantification. Further research is required to clarify its pathogenesis and optimize management strategies. Keywords: Hürthle cell carcinoma, Oncocytic thyroid lesions, Mitochondrial pathology
Zitieren
APA
Tanthry, D. L. (2026). ONCOCYTIC VARIANT OF THYROID. UP State Journal of Otorhinolaryngology and Head and Neck Surgery, 52. https://doi.org/10.36611/upjohns/volume14/issue1/10
Vancouver
Tanthry DL. ONCOCYTIC VARIANT OF THYROID. UP State Journal of Otorhinolaryngology and Head and Neck Surgery. 2026:52. doi:10.36611/upjohns/volume14/issue1/10
BibTeX
@article{Tanthry2026,
author = {Tanthry, Deepa Lakshmi},
title = {ONCOCYTIC VARIANT OF THYROID},
journal = {UP State Journal of Otorhinolaryngology and Head and Neck Surgery},
year = {2026},
pages = {52},
doi = {10.36611/upjohns/volume14/issue1/10}
}
EUVIMED